Wednesday, April 28, 2021 12:06:46 PM
I think quite a few new Therapies are in the developmental stage, with the New mRNA process gaining more popularity than the standard treatment processes! The team is working on new Treatments, as well a Vaccines, but treatments are very difficult to arrive at, as can be said for Vaccines too, IMO?
With the new process completed in the past few years, some Co's are licensing-out the Patent to use the mRNA basic process, even ELI LILLY, one of the more prominent Pharmaceutical Companies, has the right to a RGBP patent being licensed to them!
We have something new and promising, and we were in the forefront of mRNA development and Stem Cell curative treatments! It is important to remember that RGBP/Bio-Matrix focused on the latest methods when they were founded, so RGBP should have some kind of developmental advantage after 10+ years of research? GLTA....
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM